{
    "1653392658973306880": {
        "attachments": {
            "media_keys": [
                "3_1653392653529100291"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-05-02T13:35:03.000Z",
        "edit_history_tweet_ids": [
            "1653392658973306880"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 34,
                    "normalized_text": "cancer",
                    "probability": 0.7383,
                    "start": 29,
                    "type": "Other"
                },
                {
                    "end": 186,
                    "normalized_text": "TCR-T",
                    "probability": 0.5961,
                    "start": 182,
                    "type": "Other"
                },
                {
                    "end": 237,
                    "normalized_text": "CellTherapy",
                    "probability": 0.7136,
                    "start": 227,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 35,
                    "start": 28,
                    "tag": "cancer"
                },
                {
                    "end": 238,
                    "start": 226,
                    "tag": "CellTherapy"
                }
            ],
            "urls": [
                {
                    "description": "Learn more about the potential of T cell receptor therapies in cancer treatment including the capability to target solid tumours.",
                    "display_url": "spr.ly/6013OXWcT",
                    "end": 280,
                    "expanded_url": "http://spr.ly/6013OXWcT",
                    "images": [
                        {
                            "height": 392,
                            "url": "https://pbs.twimg.com/news_img/1748312163142287360/HobgPW-y?format=jpg&name=orig",
                            "width": 707
                        },
                        {
                            "height": 150,
                            "url": "https://pbs.twimg.com/news_img/1748312163142287360/HobgPW-y?format=jpg&name=150x150",
                            "width": 150
                        }
                    ],
                    "start": 257,
                    "status": 200,
                    "title": "T cell receptor therapy: A new era for cell therapy in cancer treatment",
                    "unwound_url": "https://www.astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/t-cell-receptor-therapies.html?utm_source=twitter&utm_medium=t+cell+receptor+therapies&utm_term=11889&utm_content=onc+r%26d",
                    "url": "https://t.co/dULf429GOy"
                },
                {
                    "display_url": "pic.twitter.com/k04tfMvNpb",
                    "end": 304,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1653392658973306880/photo/1",
                    "media_key": "3_1653392653529100291",
                    "start": 281,
                    "url": "https://t.co/k04tfMvNpb"
                }
            ]
        },
        "id": "1653392658973306880",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 6314,
            "like_count": 34,
            "quote_count": 0,
            "reply_count": 2,
            "retweet_count": 4
        },
        "text": "We\u2019re driving innovation in #cancer cell therapy to help achieve our ambition of putting cures within reach for patients. Our expansion into next-generation T-cell receptor therapy (TCR-T) technology explores the potential of #CellTherapy in solid tumours: https://t.co/dULf429GOy https://t.co/k04tfMvNpb"
    }
}